Impact Ethics

Disclaimer
Submit A Post
About
The Body Economy

Making a Difference in Bioethics

Tag Archives: Deborah Gleeson

Monopolies on New Medicines & Trade with the U.S.

November 14, 2018 · by impact ethics · in Pharmaceuticals, Public Health, Science and Technology

Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.

Learn about The Body Economy

Read Impact Ethics posts on The Body Economy

Watch: The Body Economy: Human Eggs in the Marketplace

Watch: The Body Economy: Surrogacy in the Marketplace

Watch: The Body Economy: Blood products in the Marketplace

Follow us on Twitter

Subscribe by email

Topics

Subscribe by RSS Feed

Bioethics Forum

The Public Charge Rule is a Eugenic Policy

Biopolitical Times

A Reading and Discussion with George Estreich

Fear & Loathing in Bioethics

"Eugene Redmond, a longtime Yale University psychiatry professor, lured students to his research site on a Caribbean island, offering financial and professional support before sexually assaulting them."

Healthy Debate

PrEP could potentially eradicate HIV. But in Ontario, only about a 10th of the people it could help are taking it.

Practical Ethics

Conscientious Objection, Professional Discretionary Space, and Good Medicine

Archives

Blog at WordPress.com.